Trending

Cosentyx

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

Swiss pharma hopes to bounce back from Q1 sales disappointment

X

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Novartis trumpets long-term data for Cosentyx in psoriasis

Novartis trumpets long-term data for Cosentyx in psoriasis

Novartis is hoping that new real world data will help its psoriasis drug Cosentyx stay ahead of rivals.

X

Novartis trumpets long-term data for Cosentyx in psoriasis

https://pharmaphorum.com/news/novartis-trumpets-long-term-data-cosentyx-psoriasis/

Imbruvica, Opdivo and Praluent gain approvals for Scotland’s NHS

Imbruvica, Opdivo and Praluent gain approvals for Scotland’s NHS

Sanofi steals a march on rivals Amgen

X

Imbruvica, Opdivo and Praluent gain approvals for Scotland’s NHS

https://pharmaphorum.com/news/imbruvica-opdivo-praluent-gain-approvals-scotlands-nhs/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com